Exencial Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.44M | Buy |
|
|||||
|
2025
Q2 | $1.71M | Buy |
|
|||||
|
2025
Q1 | $1.64M | Buy |
|
|||||
|
2024
Q4 | $1.99M | Buy |
|
|||||
|
2024
Q3 | $2.74M | Buy |
|
|||||
|
2024
Q2 | $3.19M | Sell |
|
|||||
|
2024
Q1 | $2.9M | Buy |
|
|||||
|
2023
Q4 | $2.19M | Sell |
|
|||||
|
2023
Q3 | $2.06M | Sell |
|
|||||
|
2023
Q2 | $2.01M | Buy |
|
|||||
|
2023
Q1 | $1.89M | Sell |
|
|||||
|
2022
Q4 | $11.4M | Sell |
|
|||||
|
2022
Q3 | $9.72M | Buy |
|
|||||
|
2022
Q2 | $10.5M | Sell |
|
|||||
|
2022
Q1 | $14.3M | Buy |
|
|||||
|
2021
Q4 | $13.6M | Buy |
|
|||||
|
2021
Q3 | $11M | Buy |
|
|||||
|
2021
Q2 | $9.35M | Buy |
|
|||||
|
2021
Q1 | $7.3M | Buy |
|
|||||
|
2020
Q4 | $6.82M | Sell |
|
|||||
|
2020
Q3 | $12.9M | Buy |
|
|||||
|
2020
Q2 | $5.47M | Buy |
|